Evaluation of germline sequence variants of GFRA1, GFRA2, and GFRA3 genes in a cohort of Spanish patients with sporadic medullary thyroid cancer

被引:14
作者
Borrego, S
Fernández, RM
Dziema, H
Japón, MA
Marcos, I
Eng, C
Antiñolo, G
机构
[1] Hosp Univ Virgen Rocio, Unidad Genet Med & Diagnost Prenatal, Seville 41013, Spain
[2] Hosp Univ Virgen Rocio, Dept Anat Patol, Seville 41013, Spain
[3] Ohio State Univ, Clin Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA
[4] Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA
[5] Ohio State Univ, Div Human Genet, Dept Internal Med, Columbus, OH 43210 USA
[6] Univ Cambridge, Canc Res Campaign, Human Canc Genet Res Grp, Cambridge, England
关键词
D O I
10.1089/105072502320908367
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The etiology of sporadic medullary thyroid carcinoma (sMTC) remains elusive. While germline gain-of-function mutations in the RET proto-oncogene cause hereditary MTC, somatic RET mutations have been described in a variable number of sMTC. So far, S836S of RET, is the only variant whose association with sMTC has been found in several European cohorts. Because RET variants seem to be associated with MTC, it is plausible that variants in genes encoding for RET coreceptors may play a role in the pathogenesis of sMTC. Recently, we described two possible low penetrance susceptibility alleles in the gene encoding RET coreceptor GFRalpha1, - 193C > G and 537T > C, in a German series of sMTC. In this study, we have genotyped nine polymorphisms within GFRA1-3 genes for 51 Spanish sMTC, and 100 normal controls. Our results show that no statistical signification was found when Spanish sMTC patients were compared to controls. Taken together with the observations in the German sMTC series, the present findings suggest that GFRA1-193C > G and 537T > C could be in linkage disequilibrium. with other loci responsible for the disease with a founder effect in Germany. Alternatively, the combined observations might also suggest that, if indeed the polymorphisms are functional, the effect is small.
引用
收藏
页码:1017 / 1022
页数:6
相关论文
共 35 条
[1]   Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRα3-RET receptor complex [J].
Baloh, RH ;
Tansey, MG ;
Lampe, PA ;
Fahrner, TJ ;
Enomoto, H ;
Simburger, KS ;
Leitner, ML ;
Araki, T ;
Johnson, EM ;
Milbrandt, J .
NEURON, 1998, 21 (06) :1291-1302
[2]   INCIDENCE OF SPORADIC AND FAMILIAL MEDULLARY-THYROID CARCINOMA IN SWEDEN 1959 THROUGH 1981 - A NATIONWIDE STUDY IN 126 PATIENTS [J].
BERGHOLM, U ;
ADAMI, HO ;
TELENIUSBERG, M ;
JOHANSSON, H ;
WILANDER, E .
ACTA ONCOLOGICA, 1990, 29 (01) :9-15
[3]   Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression [J].
Borrego, S ;
Sáez, ME ;
Ruiz, A ;
Gimm, O ;
López-Alonso, M ;
Antiñolo, G ;
Eng, C .
JOURNAL OF MEDICAL GENETICS, 1999, 36 (10) :771-774
[4]   RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease [J].
Borrego, S ;
Ruiz, A ;
Saez, ME ;
Gimm, O ;
Gao, X ;
López-Alonso, M ;
Hernández, A ;
Wright, FA ;
Antiñolo, G ;
Eng, C .
JOURNAL OF MEDICAL GENETICS, 2000, 37 (08) :572-578
[5]   Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase [J].
BujBello, A ;
Adu, J ;
Pinon, LGP ;
Horton, A ;
Thompson, J ;
Rosenthal, A ;
Chinchetru, M ;
Buchman, VL ;
Davies, AM .
NATURE, 1997, 387 (6634) :721-724
[6]   SINGLE MISSENSE MUTATION IN THE TYROSINE KINASE CATALYTIC DOMAIN OF THE RET PROTOONCOGENE IS ASSOCIATED WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B [J].
CARLSON, KM ;
DOU, SS ;
CHI, D ;
SCAVARDA, N ;
TOSHIMA, K ;
JACKSON, CE ;
WELLS, SA ;
GOODFELLOW, PJ ;
DONISKELLER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) :1579-1583
[7]   MUTATIONS IN THE RET PROTOONCOGENE ARE ASSOCIATED WITH MEN 2A AND FMTC [J].
DONISKELLER, H ;
DOU, SS ;
CHI, D ;
CARLSON, KM ;
TOSHIMA, K ;
LAIRMORE, TC ;
HOWE, JR ;
MOLEY, JF ;
GOODFELLOW, P ;
WELLS, SA .
HUMAN MOLECULAR GENETICS, 1993, 2 (07) :851-856
[8]  
DRACAPOLI NH, 1994, CURRENT PROTOCOLS HU, V3
[9]  
Eng C, 1996, CANCER RES, V56, P2167
[10]   RET proto-oncogene in the development of human cancer [J].
Eng, C .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :380-393